Psychedelic evolution: Mindset Pharma looks to change mental health treatment

The BioWorld Insider Podcast
21/09/2022 25 min Temporada 1 Episodio 22
Psychedelic evolution: Mindset Pharma looks to change mental health treatment

Listen "Psychedelic evolution: Mindset Pharma looks to change mental health treatment"

Descargar episodio Ver en sitio original

Episode Synopsis

James Lanthier, the CEO of Mindset Pharma Inc., talks about developing next-generation psychedelic medicines to treat neurological and psychiatric disorders. Hosted on Acast. See acast.com/privacy for more information.

More episodes of the podcast The BioWorld Insider Podcast

Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – AUDIO 29/08/2025
Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – VIDEO 27/08/2025
The importance of balancing AI and people in drug development 27/05/2025
Two CEOs discuss bracing for tariffs, NIH grant cuts and gifting China biopharma leadership position 23/04/2025
As biopharma investments stumble, med tech surges 30/03/2025
Mega money well spent? Mammoth mergers fall short of the dream 24/02/2025
Healing the health divide for women 22/11/2024
Modifi gets creative on the rocky road to a multibillion-dollar buyout 13/11/2024
A quantum leap into the future of drug development 17/10/2024
Gene and cell therapies will propel innovation, says Astellas CCO 07/10/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA